Good morning! It's Daniel de Visé with your Daily Money.
Tired of struggling with the new federal financial aid form? Colleges are, too.
Now, some schools have created their own. While the documents don't replace the 2024-2025 free application for federal student aid (FAFSA), institutions can use them to estimate financial aid awards, Medora Lee reports.
The schools are responding to delays with the rollout of a new, simplified FAFSA from the Department of Education. Read the story.
One of the wealthiest men in the world now has a lot more cash on hand.
Jeff Bezos has been unloading Amazon stock at a fast clip, Bailey Schulz reports, selling nearly 25 million shares worth $4 billion since Feb. 7. And there’s likely more to come; Amazon’s latest annual report noted that the executive chair plans to sell a total of 50 million shares by Jan. 31, 2025.
Experts say the move makes sense. Amazon shares are up, and Bezos’s recent move from Seattle to Miami means he can sell without worrying about Washington state’s new capital gains tax. Or. . . Does Bezos know something we don't? Read the story.
Music fans of a certain age will remember "Gin and Juice," a song that blasted forth from car stereos, roughly 30 years ago. Now, its creators, Snoop Dogg and Dr. Dre, have launched a series of namesake drinks.
The gin-based beverages come in four flavors, Anthony Robledo reports: Apricot, Citrus, Melon and Passionfruit. Snoop and Dre have released a promotional video, reportedly in the "Pulp Fiction" style. Follow the link above, or read the story here.
Each weekday, The Daily Money delivers the best consumer news from USA TODAY. We break down financial news and provide the TLDR version: how decisions by the Federal Reserve, government and companies impact you.
Daniel de Visé covers personal finance for USA Today.
2024-12-26 11:0785 view
2024-12-26 10:52156 view
2024-12-26 10:121151 view
2024-12-26 10:122085 view
2024-12-26 09:23936 view
2024-12-26 08:372063 view
California judges make a good living. They earn at least $240,000 and can count on a raise just abou
Supply from drugmakers for the stimulant medications most commonly prescribed for ADHD are still fal
Good morning! It's Daniel de Visé with your Daily Money.Last month, two economists from opposing ide